6 unknown. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 6 |
| Phase 2 | 2 | Unknown 2 |
Follow Acute Stroke: new trials by email Literature Review of Acute Stroke trials Research Report on Acute Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Capital Medical University | 302 | 2024-11-20 | 2024-10-29 |
| Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage Remote ischemic conditioning, Sham remote ischemic conditioning, Standard medication therapy - Intracerebral Hemorrhage, Acute Stroke | Phase 3 | Unknown | Capital Medical University | 452 | 2021-04-22 | 2022-07-19 |
| Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Tirofiban Hydrochloride, Oral antiplatelet - Acute Stroke | Phase 2 / Phase 3 | Unknown | Capital Medical University | 420 | 2020-09-12 | 2022-07-19 |
| Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Intensive antiplatelet, Standard antiplatelet, Immediate high-intensity statin - Acute Stroke, Transient Ischemic Attack | Phase 3 | Unknown | Beijing Tiantan Hospital | 6100 | 2018-09-17 | 2023-07-18 |
| Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke Insulin Glargine, Regular Insulin - Acute Stroke, Hyperglycemia | Phase 3 | Unknown | National Taiwan University Hospital | 120 | 2015-12-01 | 2016-08-19 |
| Treatment of Acute Stroke With Cromolyn(Single Dose) CROMOLYN, sugar pill - Acute Stroke | Phase 3 | Unknown | Wolfson Medical Center | 2010-08-05 |
Stroke (6) · Ischemic Stroke (2) · Cerebral Hemorrhage (1) · Cerebral Infarction (1) · Hyperglycemia (1) · Insulin Resistance (1) · Ischemic Attack, Transient (1)
Brain Diseases (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Nervous System Diseases (6) · Vascular Diseases (6) · Brain Ischemia (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Infarction (1) · Glucose Metabolism Disorders (1) · Hemorrhage (1) · Hyperinsulinism (1) · Infarction (1) · Intracranial Hemorrhages (1)
Tirofiban (2) · Aspirin (1) · Cromolyn Sodium (1) · Insulin (1) · Insulin Glargine (1) · Sugars (1)
Capital Medical University (3) · Beijing Tiantan Hospital (1) · National Taiwan University Hospital (1) · Wolfson Medical Center (1)
China (4) · Israel (1) · Taiwan (1)
Jiann-Shing Jeng, MD. PhD (1) · Yair Lampl, Neurologist (1) · Yilong Wang, MD, PhD (1)
PMID 38648030, PMID 29127270, PMID 31570084, PMID 34075142, PMID 36707080, PMID 37256974, PMID 38157499, PMID 38805216, PMID 39036300, PMID 39240565, PMID 39270151, PMID 39705390, PMID 39931900, PMID 39950764, PMID 40012523, PMID 40190261, PMID 40251953, PMID 40673545, PMID 40964718, PMID 41650951, PMID 41991239, PMID 42011250, PMID 42348803, PMID 42390058, PMID 42430849